Severe traumatic injury is a major worldwide public health issue which causes significant social and economic consequences for societies. The World Health Organization recognises road traffic accidents, suicides and homicides as the three leading causes of injury and violence-related deaths, with uncontrolled post-traumatic bleeding being the leading cause of preventable death, both in civilian life and on the battlefield. A number of national and international initiatives have sought to prevent violence- and trauma-related injuries and to also improve the management of severe bleeds in trauma patients via innovative treatment approaches, educational measures and state-of-the-art clinical practice guidelines.
Celox™ Medical, together with our parent company Medtrade, is committed to finding the fastest and most effective ways to stop bleeding, seal wounds and control infection, giving emergency responders the very best chance of saving a life, when faced with the unthinkable.